European Congress of Rheumatology (EULAR)
- Start Date:
03 Jun 2026
- End Date:
06 Jun 2026
- Location:
London
- Region:
Europe
- Booth #:
S1 & S2
Thermo Fisher Scientific is proud to be an exhibitor at the EULAR Conference 2026
Immunological, rheumatological and musculoskeletal diseases represent a significant burden for patients and society. We have extensive experience and targeted solutions to support development of programs addressing high unmet need across the disease areas. Sponsors face challenges in developing new medicines in a crowded and dynamic marketplace and we partner with them to guide every step along the way to delivering clear, high quality trial outcomes. This includes developing strategies to proactively address evolving needs such as diversity requirements in programs to meet FDA and EMA protocols.
Comprehensive immunology and rheumatology expertise
Our expertise spans a broad range of indications and includes advanced treatment modality including rarer rheumatology and immunology:
- Gout
- Hereditary angiodema
- Lupus – systemic and cutaneous lupus, lupus nephritis
- Osteoarthritis
- Osteochondromatosis
- Psoriatic arthritis
- Rheumatoid arthritis
- Systemic sclerosis
- Sjogren’s syndrome
- Vasculidites (giant cell arteritis, Behcet’s)
As immunological and rheumatology research expands treatment modalities beyond biological and targeted small molecules into mRNA technologies and cell and gene therapies, we are poised with extensive experience in these innovative treatment approaches. This includes a dedicated Cell & Gene Center of Excellence, which facilitates expertise-informed development of your asset no matter what technology or platform it employs.
To keep pace with the increase in rare disease research, our unit has expanded its dedicated resources. With experience conducting more than 70 rare immunology studies in the past five years, our team has deep knowledge of the key challenges such studies present — and how to overcome them. This knowledge enables us to guide drug developers through site identification, collaborate with key opinion leaders to support enrollment and site engagement, and partner with patient advocacy groups to ensure the patient is at the heart of study designs.
Learn more about our rheumatology expertiseSchedule a meeting or stop by Booth #S1 & S2 to learn more about our commitment to developing novel therapies that can effectively treat rheumatology diseases